CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class: Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
Symbol: CRMD on Nasdaq
Shares outstanding: 79,310,345
Price per share: $11.63
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares: 43,122,410
Total reported value: $501,522,245
% of total 13F portfolios: 0%
Share change: +8,992,075
Value change: +$101,792,720
Number of holders: 189
Price from insider filings: $11.63

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Deep Track Capital, LP	6.3%		$55,204,125		4,955,487		Deep Track Capital, LP	21 Nov 2025
SHAIBATALHAMD AYMEN ABDALKADER	5.8%	-6.7%	$44,390,000	-$440,330	4,600,000	-0.98%	SHAIBATALHAMD AYMEN ABDALKADER	01 Jan 2026
BlackRock, Inc.	7.5%		$31,244,415		4,567,897		BlackRock, Inc.	31 Dec 2024

As of 30 Sep 2025, 189 institutional investors reported holding 43,122,410 shares of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD). This represents 54% of the company’s total 79,310,345 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) together control 42% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution	Ownership %	Shares Held	Share Change %	Portfolio %	Holdings Value
BlackRock, Inc.	7.2%	5,688,303	+6.1%	0%	$66,154,964
VANGUARD GROUP INC	5%	3,977,658	-8%	0%	$46,260,163
MARSHALL WACE, LLP	4.4%	3,473,494	+35%	0.04%	$40,396,735
DEERFIELD MANAGEMENT COMPANY, L.P.	4.2%	3,323,833		0.59%	$38,656,178
STATE STREET CORP	2.3%	1,835,621	+15%	0%	$21,348,272
GEODE CAPITAL MANAGEMENT, LLC	2.3%	1,809,772	+13%	0%	$21,050,228
CITADEL ADVISORS LLC	2.2%	1,717,087	+0.17%	0.02%	$19,969,722
Alyeska Investment Group, L.P.	1.6%	1,262,979	+68%	0.04%	$14,688,446
UBS Group AG	1.4%	1,090,908	+295%	0%	$12,687,259
MORGAN STANLEY	1.1%	843,571	+9.9%	0%	$9,810,737
OBERWEIS ASSET MANAGEMENT INC/	0.99%	785,700	+62%	0.35%	$9,137,691
Jump Financial, LLC	0.98%	774,083		0.12%	$9,002,585
Nuveen, LLC	0.88%	695,724	-53%	0%	$8,091,270
KENNEDY CAPITAL MANAGEMENT LLC	0.83%	658,633	+37%	0.17%	$7,659,902
RAYMOND JAMES FINANCIAL INC	0.82%	651,987	+647%	0%	$7,582,609
Qube Research & Technologies Ltd	0.8%	637,497	+196%	0.01%	$7,414,090
NORTHERN TRUST CORP	0.78%	615,605	+8.5%	0%	$7,159,486
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.74%	584,482	+199%	0%	$6,797,526
Palisades Investment Partners, LLC	0.71%	564,106	+0.28%	2.6%	$6,560,553
Deep Track Capital, LP	0.63%	500,000		0.16%	$5,815,000
Invesco Ltd.	0.58%	456,908	+158%	0%	$5,313,839
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.57%	448,425	+136%	0.01%	$5,215,182
ROYCE & ASSOCIATES LP	0.56%	441,312		0.05%	$5,132,459
October Effect Ltd	0.53%	420,551	+36%	5.4%	$4,891,008
MILLENNIUM MANAGEMENT LLC	0.5%	395,454	+603%	0%	$4,599,130

Institutional Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q4	1,648,392	$19,176,882	+$3,422,942			$11.63	18
2025 Q3	43,122,410	$501,522,245	+$101,792,720	$15,143,423	$15,473,715	$11.63	189
2025 Q2	34,151,243	$420,700,575	+$142,838,488	$6,911,398	$10,694,248	$12.32	170
2025 Q1	23,724,937	$146,235,416	+$397,516	$4,815,472	$2,981,882	$6.16	135
2024 Q4	22,892,125	$185,427,896	+$29,941,885	$3,244,050	$4,853,520	$8.10	126
2024 Q3	19,135,638	$154,654,950	+$21,831,510	$3,565,263	$1,081,776	$8.08	100
2024 Q2	17,129,390	$74,162,456	-$748,248	$1,551,439	$305,265	$4.33	97
2024 Q1	17,269,642	$73,216,478	-$5,370,427	$1,240,624	$393,896	$4.24	89
2023 Q4	93,768	$352,568	+$269,758			$3.76	2
2023 Q3	17,891,223	$66,197,052	-$5,553,408	$1,498,500	$294,520	$3.70	92
2023 Q2	19,056,663	$75,548,463	+$32,863,790	$1,106,789	$434,785	$3.96	85
2023 Q1	10,746,095	$44,482,714	-$553,980	$1,020,480	$669,536	$4.14	63
2022 Q4	11,158,761	$46,948,867	+$1,428,377	$1,240,262	$280,926	$4.22	61
2022 Q3	10,899,717	$31,050,890	-$4,010,652	$417,000	$230,000	$2.83	64
2022 Q2	12,328,351	$48,958,929	-$6,775,110	$456,000	$220,000	$4.02	65
2022 Q1	13,362,668	$73,354,516	+$1,880,075	$618,000	$458,000	$5.48	83
2021 Q4	12,736,465	$58,004,463	+$6,443,330	$299,000	$315,000	$4.55	74
2021 Q3	11,796,601	$54,931,109	+$1,592,343	$377,000	$534,000	$4.65	77
2021 Q2	11,351,356	$77,873,368	+$3,066,297	$926,000	$1,689,000	$6.86	77
2021 Q1	10,779,619	$107,615,096	+$14,282,124	$1,737,000	$3,263,000	$9.99	76
2020 Q4	7,872,099	$58,470,909	+$6,704,405	$1,172,000	$610,000	$7.43	72
2020 Q3	7,036,991	$42,423,664	+$9,143,163	$587,000	$446,000	$6.03	69
2020 Q2	6,729,630	$42,394,689	+$1,360,448	$814,000	$275,000	$6.30	66
2020 Q1	6,555,835	$23,530,293	-$6,164,861	$457,000	$47,000	$3.59	53
2019 Q4	6,388,136	$46,494,565	+$379,977	$793,000	$104,000	$7.28	59
2019 Q3	6,369,798	$40,634,108	+$6,486,798	$497,000	$163,000	$6.38	52
2019 Q2	5,391,496	$48,346,180	+$15,523,292	$1,010,000	$1,581,000	$8.97	43
2019 Q1	3,663,429	$34,616,000	+$34,616,026	$1,543,000	$1,747,000	$9.45	41